Core Laboratories (NYSE:CLB – Get Free Report) updated its first quarter 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 0.120-0.160 for the period, compared to the consensus earnings per share estimate of 0.210. The company issued revenue guidance of $121.0 million-$127.0 million, compared to the consensus revenue estimate of $131.7 million.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on CLB shares. StockNews.com raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Citigroup reduced their price objective on Core Laboratories from $15.00 to $14.00 and set a “sell” rating for the company in a research note on Thursday, October 31st. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $17.00.
View Our Latest Analysis on CLB
Core Laboratories Stock Performance
Core Laboratories (NYSE:CLB – Get Free Report) last posted its quarterly earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share for the quarter, hitting the consensus estimate of $0.23. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%. Research analysts predict that Core Laboratories will post 0.8 earnings per share for the current fiscal year.
Core Laboratories Company Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Featured Articles
- Five stocks we like better than Core Laboratories
- Where Do I Find 52-Week Highs and Lows?
- 3 Steel Stocks Soaring After Tariff Announcements
- Why Invest in High-Yield Dividend Stocks?
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- Why Are Stock Sectors Important to Successful Investing?
- Why Salesforce Stock Could Be at Fresh Highs by February
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.